111. Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles.
Klier J, May A, Fuchs S, Schillinger U, Plank C, Winter G, Gehlen H, Coester C
Vet Immunol Immunopathol. 2011 Nov 15.
PMID: 21831455 [PubMed - in process]
112. Local application of BMP-2 specific plasmids in fibrin glue does not promote implant fixation.
Faensen B, Wildemann B, Hain C, Höhne J, Funke Y, Plank C, Stemberger A, Schmidmaier G
BMC Musculoskelet Disord. 2011 .
PMID: 21762501
113. Kidney dendritic cells induce innate immunity against bacterial pyelonephritis.
Tittel AP, Heuser C, Ohliger C, Knolle PA, Engel DR, Kurts C
J Am Soc Nephrol. 2011 Aug .
PMID: 21757770 [PubMed - in process]
114. Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasia.
Holl D, Kuckenberg P, Woynecki T, Egert A, Becker A, Huss S, Stabenow D, Zimmer A, Knolle P, Tolba R, Fischer HP, Schorle H
PLoS One. 2011 .
PMID: 21779369 [PubMed - in process]
115. A strategy to establish a gene-activated matrix on titanium using gene vectors protected in a polylactide coating.
Kolk A, Haczek C, Koch C, Vogt S, Kullmer M, Pautke C, Deppe H, Plank C
Biomaterials. 2011 Oct .
PMID: 21741701 [PubMed - in process]
116. Nuclear receptors: TH17 cell control from within.
Klotz L, Knolle P
FEBS Lett. 2011 Dec 1.
PMID: 21745474 [PubMed - in process]
117. Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism.
Schildberg FA, Wojtalla A, Siegmund SV, Endl E, Diehl L, Abdullah Z, Kurts C, Knolle PA
Hepatology. 2011 Jul .
PMID: 21488077 [PubMed - in process]
118. Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo.
Sato S, Kopitz C, Grismayer B, Beaufort N, Reuning U, Schmitt M, Luther T, Kotzsch M, Krüger A, Magdolen V
Breast Cancer Res Treat. 2011 Jun .
PMID: 20635136 [PubMed - in process]
119. MagnetofectionTM platform: from magnetic nanoparticles to novel nucleic acid therapeutics.
Plank C, Vlaskou D, Schillinger U, Mykhaylyk O
Ther Deliv. 2011 Jun .
PMID: 22822504 [PubMed - in process]
120. New opportunities in drug design of metalloproteinase inhibitors: combination between structure-function experimental approaches and systems biology.
Sela-Passwell N, Trahtenherts A, Krüger A, Sagi I
Expert Opin Drug Discov. 2011 May .
PMID: 22646077 [PubMed - in process]